Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-23T08:43:27.507Z Has data issue: false hasContentIssue false

Lunch energy density and the metabolic syndrome in patients with type 2 diabetes mellitus

Published online by Cambridge University Press:  24 April 2013

Giovana Menegotto
Affiliation:
Undergraduate Nutrition Course, School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil Division of Endocrinology, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos 2350, Prédio 12, 4° andar, 90035-003, Porto Alegre, RS, Brazil
Flávia Moraes Silva
Affiliation:
Division of Endocrinology, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos 2350, Prédio 12, 4° andar, 90035-003, Porto Alegre, RS, Brazil
Mirela Jobim de Azevedo
Affiliation:
Division of Endocrinology, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos 2350, Prédio 12, 4° andar, 90035-003, Porto Alegre, RS, Brazil Departament of Internal Medicine, School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil
Jussara Carnevale de Almeida*
Affiliation:
Division of Endocrinology, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos 2350, Prédio 12, 4° andar, 90035-003, Porto Alegre, RS, Brazil Departament of Internal Medicine, School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil
*
*Corresponding author: J. C. de Almeida, fax +55 51 3359 87 77, email [email protected]
Rights & Permissions [Opens in a new window]

Abstract

The aim of the present study was to investigate the possible associations between dietary energy density (ED) and the metabolic syndrome (MetS) in patients with type 2 diabetes. In the present case–control study, the dietary ED of 125 patients with type 2 diabetes (seventy-eight with (cases) the MetS and forty-seven without (controls) the MetS; mean age 62·0 (sd 9·4) years, mean diabetes duration 12·5 (sd 8·4) years and mean glycated Hb 7·2 (sd 1·3) %) was assessed by weighed diet records. The MetS was defined according to the 2009 Joint Interim Statement and ED by the amount of energy (kJ) in a given weight of food. Data are expressed as means (standard deviations) or medians (interquartile ranges). Patients with the MetS reported lower intakes of total energy and fibre, and a higher total food amount than the controls; the total ED did not differ, but the cases had a higher ED at lunch (mean 6·3 (sd 1·3) v. 5·9 (sd 0·8) kJ/g; P= 0·017). In this meal, patients with the MetS had lower intakes of beans (median 0·7 (interquartile range 0·4–1·1) v. 1·1 (interquartile range 0·6–1·6) g/kg; P= 0·020), vegetables (median 1·2 (interquartile range 0·6–1·7) v. 1·4 (interquartile range 1·0–2·0) g/kg; P= 0·046) and total meat (median 1·3 (interquartile range 1·0–1·6) v. 1·4 (interquartile range 1·2–1·8) g/kg; P= 0·034) than patients without the MetS. The associations between lunch ED (kJ/g) and food groups (g/kg) were confirmed for vegetables (r − 0·584; P< 0·001), fruits (r − 0·233; P= 0·070), beans (r − 0·189; P= 0·037) and oils (r 0·323; P< 0·001). In a multivariate logistic regression model, a high lunch ED was associated with the MetS (OR 6·89, 95 % CI 1·35, 35·15; P =0·020) after adjusting for confounders. In conclusion, a high ED at lunch increased the odds of the presence of the MetS in patients with type 2 diabetes. Beans and vegetables may be the major contributors to this association and their consumption might be considered to decrease ED.

Type
Full Papers
Copyright
Copyright © The Authors 2013 

The metabolic syndrome (MetS) comprises a set of inter-related risk factors for CVD and diabetes mellitus(Reference Alberti, Eckel and Grundy1). Indeed, the MetS is associated with a 2-fold increase in cardiovascular outcomes and a 1·5-fold increase in all-cause mortality in the general population(Reference Mottillo, Filion and Genest2). The prevalence of the MetS in patients with type 2 diabetes ranges from 75 to 85 %(Reference Isomaa, Almgren and Tuomi3Reference Costa, Canani and Lisboa5), and the aggregation of MetS components was significantly associated with macro-(Reference Lee and Tsai4) and microvascular complications in these patients(Reference Lee and Tsai4, Reference Abdul-Ghani, Nawaf and Nawaf6).

Coronary artery disease is the leading cause of death in patients with type 2 diabetes. However, it is widely recognised that the absolute risk of CVD varies among patients with diabetes, and an accurate assessment of risk clearly depends on individual characteristics(Reference Grundy, Benjamin and Burke7). In this context, MetS detection can contribute to the stratification of cardiovascular risk in these patients.

Lifestyle changes, including sustained 5–10 % weight loss, a moderate increase in physical activities and changes in dietary intake are the first-line strategies for treatment of the MetS(8). In this context, dietary composition has been associated with the presence of the MetS in the general population(Reference Mckeown, Meigs and Liu9Reference Esmaillzadeh and Azadbakht14) and in patients with diabetes(Reference Steemburgo, Dall'alba and Almeida15, Reference Silva, Steemburgo and De Mello16). Regarding the potential relationship between particular meals and the MetS, our group has demonstrated that patients with diabetes and the MetS have a higher-glycaemic index breakfast than diabetic patients without the MetS(Reference Silva, Steemburgo and De Mello16). In another observational study, an inverse association between regular eating meals and the presence of the MetS has been demonstrated(Reference Sierra-Johnson, Undén and Linestrand17). The meals taken during the 24 h of the day are part of one's individual eating pattern, and further exploration of meal composition is warranted. Randomised clinical trials have demonstrated the beneficial effects of particular dietary patterns such as the Mediterranean diet(Reference Esposito, Marfella and Ciotola18) and the Dietary Approaches to Stop Hypertension model(Reference Azadbakht, Mirmiran and Esmaillzadeh19) on the components of the MetS. The Dietary Approaches to Stop Hypertension diet emphasises the consumption of fruits, vegetables and low-fat dairy foods, and includes whole grains, poultry, fish and small amounts of red meat, sweets and sugar-containing beverages. The Mediterranean diet includes fruits, vegetables and whole grains, encourages the intake of nuts and fish and advocates olive oil as the main source of dietary fat(Reference Zarraga and Schwarz20). Interestingly, most foods common to both diets have low energy density (ED).

ED refers to the amount of energy (kJ) in a given weight of food. Foods with a high ED provide more energy per g than do foods with a low ED(Reference Ledikwe, Blanck and Kettel-Kahn21). Many studies have demonstrated the association between ED and obesity(Reference Ledikwe, Blanck and Kettel-Kahn22Reference Vergnaud, Estaquio and Czernichow25). However, data on the possible association between ED and the incidence of diabetes(Reference Wang, Luben and Khaw26), cardiometabolic risk factors(Reference Esmaillzadeh, Boroujeni and Azadbakht27) and, especially, the MetS(Reference Mendoza, Drewnowski and Christakis13, Reference Esmaillzadeh and Azadbakht14) are scarce. Furthermore, no studies have investigated the potential relationship between dietary ED and the MetS in patients with diabetes. Therefore, the aim of the present study was to evaluate the possible association between ED, both of the total daily diet and of main meals, and the presence of the MetS in patients with type 2 diabetes.

Methods

Patients

The present case–control study was carried out in consecutive outpatients with type 2 diabetes from the Endocrinology Division of Hospital de Clínicas de Porto Alegre between June 2008 and December 2009. Patients were selected according to the following inclusion criteria: absence of dietary counselling by a registered nutritionist in the previous 6 months and age < 80 years. Patients with BMI < 40 kg/m2, urinary albumin excretion < 300 mg/24 h, serum creatinine < 152·52 μmol/l and malabsorption were excluded because they usually receive specific dietary advice. Type 2 diabetes was defined as patients over 30 years of age at the onset of diabetes, no previous episodes of ketoacidosis or documented ketonuria and, if insulin users, the treatment with insulin began only 5 years after diagnosis(Reference Alberti, Aschner and Assal28). The study was conducted according to the guidelines laid down in the Declaration of Helsinki, and all procedures involving patients were approved by the Hospital Ethics Committee. Written informed consent was obtained from all patients.

Clinical and laboratory evaluation

Blood pressure measurements were obtained in duplicate, with the patient in a seated position after 10 min rest, using an Omron HEM-705CP sphygmomanometer (Omron Healthcare, Inc.). Patients were classified as normoalbuminuric (urinary albumin excretion < 30 mg/24 h or < 17 mg/l in a spot urine sample) or microalbuminuric (urinary albumin excretion 30–299 mg/24 h or 18–174 mg/l in a spot urine sample). Microalbuminuria was always confirmed(Reference Gross, Azevedo and Silveiro29). Physical activity was graded in levels according to activities during a typical day based on a standardised questionnaire(Reference Tuomilehto, Lindström and Eriksson30) adapted to local habits. A total of four levels were defined, ranging from sedentary lifestyle to high physical activity. Alcohol intake was taken into account when patients mentioned the current consumption of alcoholic beverages. Patients were classified as current smokers or not and self-identified as white or non-white.

The MetS was defined in this sample as the presence of two or more of the following risk factors, in addition to diabetes(Reference Alberti, Eckel and Grundy1): waist circumference ≥ 94 cm in men or ≥ 80 cm in women; serum TAG ≥ 1·70 mmol/l (or drug treatment of elevated TAG levels); serum HDL-cholesterol < 1·04 mmol/l in men or < 1·30 mmol/l in women (or drug treatment of low HDL-cholesterol levels); blood pressure ≥ 130/85 mmHg or current treatment with antihypertensive drugs(Reference Chobanian, Bakris and Black31). Patients with the MetS were allocated to the case group and the remainder as control patients.

Laboratory measurements

Blood samples were collected after a 12 h fast. Plasma glucose was measured by the glucose oxidase method, glycated Hb by an ion-exchange HPLC procedure using a reference range of 4·8–6 %(Reference Camargo, Zelmanovitz and Paggi32), total cholesterol and TAG by specific enzymatic colorimetric methods and HDL-cholesterol by the homogeneous direct method. LDL-cholesterol was estimated using the Friedewald formula (total cholesterol − HDL-cholesterol − (TAG/2·2))(Reference Friedewald, Levy and Fredrickson33) for patients with serum TAG levels < 4·52 mmol/l. Urinary creatinine was measured by Jaffe's reaction, urinary albumin excretion was measured by immunoturbidimetry (Ames-Bayer) and urinary urea N by the UV kinetic method. All tests were performed at the Hospital de Clínicas de Porto Alegre Clinical Pathology Laboratory.

Nutritional assessment

Anthropometric parameters evaluated for the assessment of nutritional status were body mass, height and waist circumference measured midway between the lowest rib margin and the iliac crest. Measurements were obtained with medical scales and a non-stretch fibreglass tape measure. BMI was calculated.

The patient's usual diet was assessed by means of the 3 d weighed diet record technique (two non-consecutive weekdays and one weekend day) as standardised previously(Reference Moulin, Tiskievicz and Zelmanovitz34). Compliance with the weight record technique was confirmed by comparison between the protein intake estimate from weighed diet records and the 24 h urinary N output. To be included in the present study, patients had to have an acceptable ratio, between the two protein intake estimates, from 0·79 to 1·26, and values out of this range were considered ‘under- or over-reporting’ (Reference Vaz, Bittencourt and Almeida35). Therefore, fifty patients were not included in the present study. Nutritional composition from diet records was calculated with Nutribase 2007 Clinical Nutritional Manager software version 7.14 (Cybersoft) and updated(36).

ED was estimated taking into account only solid foods, excluding all fluids from analyses: ED = energy from the solid food consumed divided by the weight of the solid food consumed(Reference Ledikwe, Blanck and Kettel-Kahn21). Foods were grouped for analyses: ‘cereals, tubers and roots’, ‘fruit’, ‘vegetables’, ‘beans’, ‘meat and eggs’, ‘oils and fats’ and ‘sweets’.

Statistical analysis

The 85 % prevalence of the MetS in patients with type 2 diabetes(Reference Costa, Canani and Lisboa5) and a 1·05 kJ/g difference in ED between the cases (mean 7·49 (sd 1·67) kJ/g) and controls (mean 6·44 (sd 1·26) kJ/g) obtained after a preliminary pilot study of the usual diet in patients with type 2 diabetes (fifteen patients with and fifteen patients without the MetS) were considered to calculate the sample size. The minimum sample size was sixty cases and thirty controls, with 80 % power and an α of 0·05.

The Gaussian distribution of variables was tested by one-sample Kolmogorov–Smirnov and Shapiro–Wilk tests. Variables are expressed as mean (standard deviation), median (interquartile range) or number (percentage) of patients with the analysed characteristic. Patient characteristics (cases v. controls) were compared using Student's t test, the Mann–Whitney U test, and Pearson's χ2 or Fisher's exact test (adjusted standardised residual was adopted as appropriate). Fibre intakes (total, soluble and insoluble) were adjusted for total energy intake according to the residual method(Reference Willett, Howe and Kushi37). Multiple logistic regression models were constructed to assess the possible associations of dietary ED with the presence of the MetS (dependent variable). Analyses were adjusted for confounding variables selected according to clinical relevance or their significance (P< 0·10) on univariate analyses: sex; duration of diabetes; glycated Hb; fibre intake. P values < 0·05 (two-sided) were considered as statistically significant. All analyses were performed using PASW 18.0 (SPSS, Inc.).

Results

A total of seventy-eight patients with the MetS (62·4 %; cases) and forty-seven without the MetS (controls) were studied. Their main clinical and laboratory characteristics according to the presence of the MetS are described in Table 1. A higher proportion of women was observed in the MetS group. Patients with the MetS also had a shorter duration of diabetes, lower glycated Hb values and were more overweight when compared with the controls. Differences in the prevalence of MetS components were observed, as expected. There were no differences in age, lifestyle characteristics, microalbuminuria, and fasting blood glucose, total cholesterol or LDL-cholesterol between the two groups. In this sample of patients with type 2 diabetes (n 125), the most prevalent component of the MetS was high blood pressure (76·0 %), followed by abnormal waist circumference (64·0 %), hypertriacylglycerolaemia (33·6 %) and low HDL-cholesterol values (30·4 %).

Table 1 Clinical and laboratory characteristics of patients with type 2 diabetes according to the presence or absence of the metabolic syndrome (MetS) (Mean values and standard deviations; medians and 25th–75th percentiles; percentages)

HbA1c, glycated Hb.

* Student's t test.

Pearson's χ2.

Mann–Whitney U test.

The characteristics of the usual diet of the studied patients are described in Table 2. Patients with the MetS had a higher total energy intake and a lower intake of total dietary fibre, soluble and insoluble fibre (crude and energy-adjusted values) than the controls. The distribution of the macronutrients was as follows: 46·2 (sd 8·5) % energy from carbohydrates, 18·8 (sd 3·4) % energy from protein and 33·5 (sd 7·7) % energy from fat, with no significant differences between the patients with and without the MetS. Furthermore, there were no differences in the proportion of SFA, MUFA, PUFA and trans-unsaturated fatty acid intakes between the two groups.

Table 2 Characteristics of the usual diet of patients with type 2 diabetes according to the presence or absence of the metabolic syndrome (MetS) (Mean values and standard deviations; medians and 25th–75th percentiles)

TEI, total energy intake; TFA, trans-fatty acids.

* Student's t test.

Mann–Whitney U test.

Fibre intake values (total, soluble and insoluble) were adjusted for total energy intake according to the residual method.

All patients reported eating the three main meals of the day (breakfast, lunch and dinner), without differences between the patients with and without the MetS. It was observed that one-quarter of patients did not have a mid-morning snack (23 % of cases v. 21 % of controls; P= 0·499), 4 % of cases did not have an afternoon snack, whereas all controls did (P= 0·239), and one-third of patients did not have supper (32 % in both groups; P= 0·574). We analysed ED values for the overall diet and the ED of each meal (Table 3). Patients with the MetS had a higher lunch ED when compared with patients without the MetS. There were no significant differences in total dietary ED or the ED of the other meals.

Table 3 Energy density values in the usual diet of patients with type 2 diabetes according to the presence or absence of the metabolic syndrome (MetS) (Mean values and standard deviations; medians and 25th–75th percentiles)

* Student's t test.

Mann–Whitney U test.

The amount of food eaten was evaluated in patients with and without the MetS. Patients with the MetS had a higher total food intake during the day (mean 1145·0 (sd 260·7) v. 1041·1 (sd 289·2) g; P= 0·041), but ate less at lunch (median 411·4 (interquartile range 346·9–506·4) v. 485·8 (interquartile range 374·6–562·7) g; P= 0·028) and dinner (median 245·2 (interquartile range 167·1–328·1) v. 306·0 (interquartile range 227·5–388·7) g; P= 0·032) than the controls. There were no differences between the patients with and without the MetS in the amount of daily energy fluids consumed (median 311·5 (interquartile range 190·4–470·8) v. 371·7 (interquartile range 170·0–608·3) ml; P= 0·324) or total energy intake from fluids (median 585·8 (interquartile range 322·2–866·1) v. 765·5 (interquartile range 343·1–1167·3) kJ; P= 0·190). Regarding energy intake, patients with the MetS consumed less energy at dinner (median 1815·9 (interquartile range 1493·7–2397·4) v. 2305·4 (interquartile range 1623·4–2702·7) kJ; P= 0·027) than the controls, without any difference at the other meals (data not shown). ED was evaluated, per 24 h period and at each meal, according to the groups divided by the presence of normal or abnormal individual components of the MetS. These analyses failed to identify any between-group differences (Table S1, available online).

We also conducted analyses according to the intake of food groups in order to better understand the observed differences at lunch (ED and the amount of food consumed) in patients with and without the MetS. The amount of food from each group eaten by the cases and the controls is reported in Table 4. Patients with the MetS ate less (g/kg body weight) beans, vegetables and meat than the controls. In a sub-analysis regarding the type of meats, a greater proportion of patients with the MetS ate red meat than patients without the MetS (94·7 v. 82·2 %; P= 0·028), without differences in the proportion of patients who ate white meat (64·0 v. 68·9 %; P= 0·585). No differences were observed between the patients with and without the MetS regarding the amount of consumed red (median 65·0 (interquartile range 37·0–81·7) v. 60·0 (interquartile range 18·3–97·5) g; P= 0·651) or white meats (median 26·7 (interquartile range 0–43·3) v. 36·7 (interquartile range 0–62·7) g; P= 0·379), respectively.

Table 4 Food groups at lunch of patients with type 2 diabetes according to the presence or absence of the metabolic syndrome (MetS) (Medians and interquartile ranges)

* Mann–Whitney U test.

Considering data from all patients (n 125), correlation coefficients between lunch ED and food groups (g/kg body weight) consumed at lunch were significant for vegetables (r −0·584; P< 0·001), fruits (r −0·233; P= 0·070), beans (r −0·189; P= 0·037) and oils (r 0·323; P< 0·001). We did not observe correlations of lunch ED with meats (white or red), cereals and sweets (data not shown).

In the multiple logistic regression model, lunch ED was associated with the presence of the MetS: an increase of 4·184 kJ/g in lunch ED was associated with a greater than 6-fold increase in the odds of the MetS (OR 6·89, 95 % CI 1·35, 35·15; P =0·020), after adjusting for sex (OR 3·04, 95 % CI 1·33, 6·96; P =0·008), diabetes duration (OR 0·95, 95 % CI 0·91, 1·00; P= 0·058), glycated Hb (OR 0·69, 95 % CI 0·49, 0·97; P= 0·032) and total energy-adjusted fibre intake at lunch (OR 0·94, 95 % CI 0·84, 1·07; P= 0·349).

Discussion

In the present case–control study, lunch ED was independently associated with the presence of the MetS, with the odds of the MetS increasing 6·30 times for each 4·184 kJ/g increment in lunch ED. This was the first study to explore the relationship between meal ED and a co-morbidity outcome in patients with type 2 diabetes.

Other authors(Reference Mendoza, Drewnowski and Christakis13Reference Esmaillzadeh and Azadbakht14) have reported weaker associations between ED and the MetS in patients without diabetes when compared with the present results, possibly due to the variability in the prevalence of the MetS in different populations. In fact, approximately 85 % of patients with type 2 diabetes have the MetS(Reference Costa, Canani and Lisboa5), whereas the prevalence is lower (20–25 %) in the general population(8). Mendoza et al. (Reference Mendoza, Drewnowski and Christakis13) reported that a 10 % increase in the prevalence of the MetS could be attributed to a 4·10 kJ/g increase in the dietary ED of US adults. In Iranian women, high-ED diets were associated with 54 % higher odds for the MetS compared with women who consumed a lower-ED diet (a difference of − 2·0 kJ/g)(Reference Esmaillzadeh and Azadbakht14). Finally, the impact of ED may be greater in individuals with a greater predisposition for the MetS as occurs with type 2 diabetic patients.

In view of the significant difference in lunch ED between the patients with and those without the MetS, and considering that this difference may have been due to a greater intake of high-ED foods, we analysed the intake amount according to food groups consumed. Patients with the MetS ate less beans, vegetables and meat, which may at least partly explain (especially the reduced intake of vegetables and beans) the higher lunch ED. Beans and vegetables are low-ED foods, mostly due to their extremely high water content (approximately 80 and >90 %, respectively), are relevant sources of dietary fibre and have a low glycaemic index – all characteristics associated with a low MetS prevalence in patients with diabetes(Reference Steemburgo, Dall'alba and Almeida15, Reference Silva, Steemburgo and De Mello16). Furthermore, lunch accounted for 37·4 (sd 9·3) % of the total energy intake of this sample of patients with diabetes and could partially explain the results observed, considering that this meal was the major contributor to daily energy intake, with a significant difference (general linear model analysis; P< 0·001) on comparison with the other five meals.

The links between ED and the MetS are poorly understood. The high glycaemic index and the amount of saturated fat observed in high-ED diets may contribute to the development of insulin resistance(Reference Liese, Schulz and Fang38, Reference Riccardi, Giacco and Rivellese39). The relationship between ED and insulin resistance/sensitivity could help explain its links with the MetS, especially due to the importance of insulin resistance to the pathophysiology of the MetS(Reference Schmidt40).

We took particular care with some methodological aspects of the present study, such as the choice of dietary records and the formula to estimate the ED of foods. Information on habitual dietary intake was obtained by means of a 3 d weighed diet record, a method previously validated by using a biomarker (protein intake) in patients with type 2 diabetes(Reference Moulin, Tiskievicz and Zelmanovitz34). Furthermore, only patients whose dietary records were not considered implausible were included in the study(Reference Vaz, Bittencourt and Almeida35). Regarding dietary ED, although a variety of methods are available(Reference Ledikwe, Blanck and Kettel-Kahn21, Reference Cox and Mela41), we chose to conduct the present analyses on the basis of solid foods alone, due to the lower within-person variability of solid-food ED(Reference Ledikwe, Blanck and Kettel-Kahn21). This estimation method has been recommended(Reference Hartline-grafton, Rose and Johnson23) because fluid intake generally has no impact on overall energy intake but increases the volume of food ingested over the course of a day, thus reducing the overall ED. Moreover, the contribution of fluids towards daily energy intake in our sample was lower than 10 %.

One possible limitation of the present study includes the greater proportion of women in the MetS group when compared with patients without the MetS. This weakness could preclude the generalisation of the present findings. However, the prevalence of the MetS can differ between sexes (greater in males than in females), as reported elsewhere(Reference Isomaa, Almgren and Tuomi3, Reference Lee and Tsai4). Finally, we included sex as an independent variable in the multivariate analysis and the association of ED with the MetS was maintained. Although we have presented a power calculation to justify the sample size, the significance of the reported results should be interpreted with caution, because many statistical tests were performed in the present study, which increases the chance of type I error.

The present results showed that, in patients with type 2 diabetes, lunch food choices that reduce ED are inversely associated with the presence of the MetS. An increase in the intake of beans and vegetables should be the focus of patients' dietary changes at lunch in order to achieve reductions in lunch ED. Beans are good sources of vegetable protein and fibre and their daily intake has been encouraged for the general population(Reference Leterme4244), as well as the consumption of at least five daily servings of fruit and vegetables (approximately 400 g/d)(45). The addition of two servings of vegetables (e.g. four tomato slices (80 g) and one serving spoonful of raw carrots (40 g), or three slices of boiled beet (40 g) and three tablespoonfuls of cooked spinach (70 g)) in a lunch consisting of 125 g rice, 100 g beans and one 100 g serving of white meat would lead to a reduction in ED of the order of 1·05 kJ/g, and should therefore be encouraged.

In conclusion, eating a high-ED lunch is associated with a 6-fold increase in the presence of the MetS in patients with type 2 diabetes. Beans and vegetables appear to be the key foods for reducing lunch ED, and should be considered in further research on dietary advice in these patients. In this regard, randomised clinical trials are required to evaluate the impact of these strategies on the prevention and treatment of the MetS in these patients.

Supplementary material

To view supplementary material for this article, please visit http://dx.doi.org/10.1017/S0007114513000846

Acknowledgements

Financial support for the present study was provided by the Fundo de Incentivo à Pesquisa e Eventos do Hospital de Clínicas de Porto Alegre. G. M. was responsible for the data collection, analyses and interpretation of the data and wrote the manuscript, taking into account the comments from all co-authors. F. M. S., M. J. d. A. and J. C. d. A. contributed to the study conception and design, analyses and interpretation of the data. J. C. d. A., who is the overall coordinator of the project, reviewed the manuscript and contributed to the data interpretation and the discussion of the results. The authors declare no conflict of interest.

References

1Alberti, KG, Eckel, RH, Grundy, SM, et al. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 16401645.Google Scholar
2Mottillo, S, Filion, KB, Genest, J, et al. (2010) The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 56, 11131132.Google Scholar
3Isomaa, B, Almgren, P, Tuomi, T, et al. (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24, 683689.Google Scholar
4Lee, YJ & Tsai, JC (2002) Ace gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care 25, 10021008.Google Scholar
5Costa, LA, Canani, LH, Lisboa, HRK, et al. (2004) Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in type 2 diabetes. Diabet Med 21, 252255.Google Scholar
6Abdul-Ghani, M, Nawaf, G, Nawaf, F, et al. (2006) Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome. IMAJ 8, 378382.Google Scholar
7Grundy, SM, Benjamin, IJ, Burke, GL, et al. (1999) Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 100, 11341146.Google Scholar
8Alberti KG, Zimmet PZ, Shaw J, et al. (2006) International Diabetes Federation. The IDF Consensus Worldwide Definition of the Metabolic Syndrome. Brussels: IDF Communications.Google Scholar
9Mckeown, MN, Meigs, JB, Liu, S, et al. (2004) Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort. Diabetes Care 27, 538546.CrossRefGoogle ScholarPubMed
10Esmaillzadeh, A, Mirmiran, P & Azizi, F (2005) Whole-grain consumption and the metabolic syndrome: a favorable association in Tehranian adults. Eur J Clin Nutr 59, 353362.CrossRefGoogle ScholarPubMed
11Freire, RD, Cardoso, MA, Gimeno, SGA, et al. (2005) Dietary fat is associated with metabolic syndrome in Japanese Brazilians. Diabetes Care 28, 17791785.CrossRefGoogle ScholarPubMed
12Sahyoun, NR, Jacques, PF, Zhang, XL, et al. (2006) Whole-grain intake is inversely associated with the metabolic syndrome and mortality in older adults. Am J Clin Nutr 83, 124131.Google Scholar
13Mendoza, JA, Drewnowski, A & Christakis, DA (2007) Dietary energy density is associated with obesity and the metabolic syndrome in US adults. Diabetes Care 30, 974979.Google Scholar
14Esmaillzadeh, A & Azadbakht, L (2011) Dietary energy density and the metabolic syndrome among Iranian women. Eur J Clin Nutr 65, 598605.Google Scholar
15Steemburgo, T, Dall'alba, V, Almeida, JC, et al. (2009) Intake of soluble fibers has a protective role for the presence of metabolic syndrome in patients with type 2 diabetes. Eur J Clin Nutr 63, 127133.Google Scholar
16Silva, FM, Steemburgo, T, De Mello, VD, et al. (2011) High dietary glycemic index and low fiber content are associated with metabolic syndrome in patients with type 2 diabetes. J Am Coll Nutr 30, 141148.Google Scholar
17Sierra-Johnson, J, Undén, AL, Linestrand, M, et al. (2008) Eating meals irregularly: a novel environmental risk factor for the metabolic syndrome. Obesity 16, 13021307.CrossRefGoogle ScholarPubMed
18Esposito, K, Marfella, R, Ciotola, M, et al. (2004) Effect of a Mediterranean-style diet on endothelial dysfunction and markers of a vascular inflammation in the metabolic syndrome – a randomized trial. JAMA 292, 14401446.CrossRefGoogle ScholarPubMed
19Azadbakht, L, Mirmiran, P, Esmaillzadeh, A, et al. (2005) Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome. Diabetes Care 28, 28232831.Google Scholar
20Zarraga, IGE & Schwarz, ER (2006) Impact of dietary patterns and interventions on cardiovascular health. Circulation 114, 961973.CrossRefGoogle ScholarPubMed
21Ledikwe, J, Blanck, H, Kettel-Kahn, L, et al. (2005) Dietary energy density determined by eight calculation methods in a nationally representative United States population. J Nutr 135, 273278.Google Scholar
22Ledikwe, JH, Blanck, HM, Kettel-Kahn, LK, et al. (2006) Dietary energy density is associated with energy intake and weight status in US adults. Am J Clin Nutr 83, 13621368.Google Scholar
23Hartline-grafton, HL, Rose, D, Johnson, CC, et al. (2006) Energy density of foods, but not beverages, is positively associated with body mass index in adult women. Eur J Clin Nutr 63, 14111418.Google Scholar
24Johnson, L, Wilks, DC, Lindroos, AK, et al. (2009) Reflections from a systematic review of dietary energy density and weight gain: is the inclusion of drinks valid? Obes Rev 10, 681692.Google Scholar
25Vergnaud, AC, Estaquio, C, Czernichow, S, et al. (2009) Energy density and 6-year anthropometric changes in a middle-aged adult cohort. Br J Nutr 102, 302309.Google Scholar
26Wang, J, Luben, R, Khaw, K-T, et al. (2008) Dietary energy density predicts the risk of incident type 2 diabetes: The European Prospective Investigation of Cancer (EPIC)-Norfolk Study. Diabetes Care 31, 21202125.Google Scholar
27Esmaillzadeh, A, Boroujeni, HK & Azadbakht, L (2012) Consumption of energy-dense diets in relation to cardiometabolic abnormalities among Iranian women. Public Health Nutr 15, 868875.Google Scholar
28Alberti, KG, Aschner, P, Assal, J-P, et al. (1999) Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization Publications.Google Scholar
29Gross, JL, Azevedo, MJ, Silveiro, SP, et al. (2005) Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28, 164176.Google Scholar
30Tuomilehto, J, Lindström, J, Eriksson, JG, et al. (2001) Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344, 13431350.Google Scholar
31Chobanian, AV, Bakris, GL, Black, HR, et al. (2005) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289, 25602572.Google Scholar
32Camargo, JL, Zelmanovitz, T, Paggi, A, et al. (1998) Accuracy of conversion formula for estimation of glycohaemoglobin. Scand J Clin Lab Invest 58, 521528.Google Scholar
33Friedewald, WT, Levy, RI & Fredrickson, DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499502.Google Scholar
34Moulin, CC, Tiskievicz, F, Zelmanovitz, T, et al. (1998) Use of weighed diet records in the evaluation of diets with different protein contents in patients with type 2 diabetes. Am J Clin Nutr 67, 853857.Google Scholar
35Vaz, JS, Bittencourt, M, Almeida, JC, et al. (2008) Protein intake estimated by weighed diet records in type 2 diabetic patients: misreporting and intra-individual variability using 24-hour nitrogen output as criterion standard. J Am Diet Assoc 108, 867872.Google Scholar
36USDA SR 17 (2007) Research Quality Nutrient Data. The Agricultural Research Service: Composition of Foods, Agricultural Handbook no. 8. Washington, DC: US Department of Agriculture.Google Scholar
37Willett, WC, Howe, GR & Kushi, LH (1997) Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 65, 12201228.Google Scholar
38Liese, AD, Schulz, M, Fang, F, et al. (2005) Dietary glycemic index and glycemic load, carbohydrate and fiber intake, and measures of insulin sensitivity, secretion, and adiposity in the Insulin Resistance Atherosclerosis Study (2005). Diabetes Care 28, 28322838.Google Scholar
39Riccardi, G, Giacco, R & Rivellese, AA (2004) Dietary fat, insulin sensitivity and metabolic syndrome. Clin Nutr 23, 447456.CrossRefGoogle Scholar
40Schmidt, AM (2012) Insulin resistance and metabolic syndrome: mechanisms and consequences. Arterioscler Thromb Vasc Biol 32, 1753.Google Scholar
41Cox, DN & Mela, DJ (2000) Determination of energy density of freely selected diets: methodological issues and implications. Int J Obes Relat Metab Disord 24, 4954.Google Scholar
42Leterme, P (2002) Recommendations by health organizations for pulse consumption. Br J Nutr 88, Suppl. 3, 239242.CrossRefGoogle ScholarPubMed
43United States Department of Agriculture (2010) Dietary Guidelines for Americans. Washington, DC: USDA Publications.Google Scholar
44Secretaria de Atenção à Saúde, Departamento de Atenção Básica, Coordenação Geral da Política de Alimentação e Nutrição (2006) Guia Alimentar para a População Brasileira: promovendo a alimentação saudável. Brasília: Ministério da Saúde. http://nutricao.saude.gov.br/guia_conheca.php (accessed 5 March 2013). Google Scholar
45World Health Organization (2003) WHO Fruit and Vegetable Promotion Initiative – Report of the Meeting. Geneva: WHO.Google Scholar
Figure 0

Table 1 Clinical and laboratory characteristics of patients with type 2 diabetes according to the presence or absence of the metabolic syndrome (MetS) (Mean values and standard deviations; medians and 25th–75th percentiles; percentages)

Figure 1

Table 2 Characteristics of the usual diet of patients with type 2 diabetes according to the presence or absence of the metabolic syndrome (MetS) (Mean values and standard deviations; medians and 25th–75th percentiles)

Figure 2

Table 3 Energy density values in the usual diet of patients with type 2 diabetes according to the presence or absence of the metabolic syndrome (MetS) (Mean values and standard deviations; medians and 25th–75th percentiles)

Figure 3

Table 4 Food groups at lunch of patients with type 2 diabetes according to the presence or absence of the metabolic syndrome (MetS) (Medians and interquartile ranges)

Supplementary material: PDF

Menegotto Supplementary Material

Table S1

Download Menegotto Supplementary Material(PDF)
PDF 75.1 KB